254 related articles for article (PubMed ID: 16474940)
21. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
22. Re: "Rifampin and linezolid in the treatment of methicillin-resistant Staphylococcus aureus preseptal cellulitis".
Pagani L; Vedovelli C; Coser S; Mian P
Ophthalmic Plast Reconstr Surg; 2010; 26(5):389; author reply 389-90. PubMed ID: 20502365
[No Abstract] [Full Text] [Related]
23. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Ruiz ME; Guerrero IC; Tuazon CU
Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Melzer M; Goldsmith D; Gransden W
Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
[No Abstract] [Full Text] [Related]
25. Rifampin and linezolid in the treatment of methicillin-resistant Staphylococcus aureus preseptal cellulitis.
Bababeygy SR; Silva RA; Sun Y; Jain A
Ophthalmic Plast Reconstr Surg; 2009; 25(3):227-8. PubMed ID: 19454937
[TBL] [Abstract][Full Text] [Related]
26. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases.
Sipahi OR; Bardak S; Turhan T; Arda B; Pullukcu H; Ruksen M; Aydemir S; Dalbasti T; Yurtseven T; Zileli M; Ulusoy S
Scand J Infect Dis; 2011 Oct; 43(10):757-64. PubMed ID: 21671825
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.
Yanagihara K; Kaneko Y; Sawai T; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Tashiro T; Murata I; Kohno S
Antimicrob Agents Chemother; 2002 Oct; 46(10):3288-91. PubMed ID: 12234863
[TBL] [Abstract][Full Text] [Related]
28. Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: a case report and literature review.
Manfredi R; Sabbatani S; Chiodo F
Scand J Infect Dis; 2005; 37(6-7):513-7. PubMed ID: 16012016
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
de Feiter PW; Jacobs JA; Jacobs MJ; Vink C; van der Geest S
Scand J Infect Dis; 2005; 37(3):173-6. PubMed ID: 15849048
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
[TBL] [Abstract][Full Text] [Related]
31. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
32. Linezolid treatment of ventriculoperitoneal shunt infection without implant removal.
Castro P; Soriano A; Escrich C; Villalba G; Sarasa M; Mensa J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):603-6. PubMed ID: 16187055
[TBL] [Abstract][Full Text] [Related]
33. Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial.
Li Z; Willke RJ; Pinto LA; Rittenhouse BE; Rybak MJ; Pleil AM; Crouch CW; Hafkin B; Glick HA
Pharmacotherapy; 2001 Mar; 21(3):263-74. PubMed ID: 11256381
[TBL] [Abstract][Full Text] [Related]
34. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid.
Mogenet I; Raetz-Dillon S; Canonge JM; Archambaud M; Bonnet E
Ann Pharmacother; 2004 Jun; 38(6):986-8. PubMed ID: 15113981
[TBL] [Abstract][Full Text] [Related]
36. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
Powers JH; Ross DB; Lin D; Soreth J
Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
[No Abstract] [Full Text] [Related]
37. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Hachem R; Afif C; Gokaslan Z; Raad I
Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
[No Abstract] [Full Text] [Related]
38. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
39. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
40. Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
Howden BP; Charles PG; Johnson PD; Ward PB; Grayson ML
Antimicrob Agents Chemother; 2005 Nov; 49(11):4816; author reply 4816-7. PubMed ID: 16251343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
